Meridian Bioscience, Inc. (NASDAQ:VIVO)
CAPS Rating:
A fully-integrated life science company whose principal businesses are development, manufacture, sale and distribution of diagnostic test kits; manufacture and distribution of bulk antigens and reagents; and manufacture of proteins and other biologicals.
RSS Headlines
Fool UK
Recs
msn screen:
5 year div. growth >= 20 %
annual eps growth >= 25%
debt/eq <= 0.5
current dividend >= 2.5%